Boom Or Bust? N G [email protected] E
Total Page:16
File Type:pdf, Size:1020Kb
Best World S$2.20 - SELL C h a Horng Han Low Boom or bust? n g [email protected] e China growth reminiscent of earlier boom-and-bust experiences i +65 6416 7847 n Best World’s (BW) strong growth has typically been underpinned by a single t a r country: Indonesia had anchored 2006-08 growth before revenue collapsed; g e Taiwan was the focus during 2013-16 before an unexpected decline in 2017. In t p both instances, sales have failed to recover. With China sales surging, r i c momentum in 2019 is set to continue, but we are concerned if the strong growth e is sustainable. This is underscored by results of an online search on Baidu/WeChat, where the direct-selling company’s flagship brand, Dr’s Secret, is ranked much lower than peers. Our revised numbers are below consensus. 2 April 2019 Maintain SELL to a new S$1.75 target (from S$1.29). Singapore The boom-bust experience in Indonesia Consumer Despite a diversified geographical exposure, BW’s strong performance is usually anchored to a single country. Prior to the 2008 crisis, Indonesia had been a key Reuters BEST.SI driver as BW successfully engaged the Indo community in Singapore to distribute Bloomberg BEST SP in Indonesia. Although there were regulatory issues regarding imports in 2009, Priced on 1 April 2019 BW did adapt by enhancing the product mix. However, sales have failed to STI @ 3,250.5 recover despite a recovery in Indonesia’s GDP after the crisis. 12M hi/lo S$3.30/1.20 Revisiting our May 2017 cautious view on Taiwan 12M price target S$1.75 ±% potential -20% We expressed concerns in May 2017 - despite BW delivering above-consensus estimates (thanks to China) - due to an unexpected slowdown in Taiwan. We attributed the sharp Shares in issue 554.4m Free float (est.) 45.0% slowdown to inventory overbuild among distributors. Sales in Taiwan have yet to recover from 2017-18 levels despite BW’s efforts to improve its market positioning. Market cap US$892m 3M ADV US$7.7m Red flags in China as consumer interest trails revenue outperformance Foreign s'holding 60.0% China is now BW’s key market (54% of revenue). A stronger-than-expected 4Q18 implies momentum in 2019 will continue, but we are concerned the issues faced in Major shareholders D2 Investments Pte Ltd 35.0% Indonesia and Taiwan could repeat. Our online study on the Chinese market using Baidu/WeChat Trends API, however, indicates weak consumer interest (proxy via the number of domestic searches) on BW and its product, Dr’s Secret (晳之密). China, being a relatively new market, explains its strong performance as they expand distributors during the initial phase, but the significant gap between consumer interest and revenue Blended ESG Score (%)* implies momentum could stall once the number of distributors reaches saturation. Overall 64.7 Country average 69.3 Retain SELL with new S$1.75 target GEM sector average 64.0 *Click to visit company page on clsa.com for details Our revised estimates suggest a strong 2019 (16% above Bloomberg consensus as earnings could surprise) before a decline in 2020-21 (32-44% below as end demand sell- Stock performance (%) through could be challenged). Our S$1.75 target is based on 12x PE (avg 19-21CL EPS). 1M 3M 12M Absolute (5.6) (16.3) 20.2 Financials Relative (6.5) (21.0) 26.8 Year to 31 December 17A 18A 19CL 20CL 21CL Abs (US$) (5.6) (15.8) 16.3 Revenue (S$m) 215 266 476 380 375 3.4 (S$) (%) 300 Rev forecast change (%) - - 74.4 24.7 - 250 Net profit (S$m) 56 73 105 70 64 2.8 200 NP forecast change (%) - - 70.0 (4.0) - EPS (S¢) 10.1 13.3 19.2 12.8 11.7 2.2 150 CL/consensus (3) (EPS%) - - 132 80 69 100 1.5 EPS growth (% YoY) 61.2 31.1 44.7 (33.4) (8.2) 50 PE (x) 21.7 16.6 11.5 17.2 18.7 0.9 0 Dividend yield (%) 1.9 2.8 3.0 2.3 2.3 Apr-17 Oct-17 Apr-18 Oct-18 Best World (LHS) ROE (%) 50.6 48.1 49.6 25.7 19.6 Rel to STI (RHS) Net debt/equity (%) (63.2) (115.4) (65.6) (66.5) (67.8) Source: Bloomberg Consensus numbers from Thomson Reuters. Source: www.clsa.com Find CLSA research on Bloomberg, Thomson Reuters, Factset and CapitalIQ - and profit from our evalu@tor proprietary database at clsa.com For important disclosures please refer to page 22. Boom or bust? Best World - SELL Financials at a glance Year to 31 December 2017A 2018A 2019CL (% YoY) 2020CL 2021CL Profit & Loss (S$m) Revenue 215 266 476 78.8 380 375 Cogs (ex-D&A) (64) (56) (116) (101) (107) Gross Profit (ex-D&A) 151 210 360 71.5 278 268 SG&A and other expenses (75) (115) (219) (182) (178) Op Ebitda 76 95 141 48.3 97 90 Depreciation/amortisation (5) (3) (3) (5) (6) Op Ebit 71 93 138 48.9 92 84 Net interest inc/(exp) 0 1 0 (76.3) 0 0 Other non-Op items (4) 0 (1) (1) 0 Profit before tax 68 93 137 47.6 92 84 Taxation (13) (21) (31) (21) (19) Profit after tax 55 73 107 46.8 71 65 Minority interest 1 0 (1) (1) (1) Net profit 56 73 105 44.7 70 64 Adjusted profit 59 73 106 45 71 65 Cashflow (S$m) 2017A 2018A 2019CL (% YoY) 2020CL 2021CL Operating profit 71 93 138 48.9 92 84 Depreciation/amortisation 5 3 3 24.4 5 6 Working capital changes (3) 71 (111) (9) (7) Other items (16) (15) (32) (21) (20) Net operating cashflow 57 150 (1) 67 64 Capital expenditure - - - - - Free cashflow 57 150 (1) 67 64 M&A/Others (11) (1) (7) (6) (6) Net investing cashflow (11) (1) (7) (6) (6) Increase in loans 0 (5) 0 0 0 Dividends (17) (27) (36) (27) (27) Net equity raised/other (4) (1) 1 (4) (1) Net financing cashflow (20) (34) (35) (32) (29) Incr/(decr) in net cash 25 115 (43) 29 29 Exch rate movements 8 8 8 0 8 8 Balance sheet (S$m) 2017A 2018A 2019CL (% YoY) 2020CL 2021CL Cash & equivalents 82 197 154 (21.8) 183 212 Accounts receivable 47 5 26 399.8 26 31 Other current assets 43 63 80 28.2 86 89 Fixed assets 8 8 16 90.6 20 22 Investments 0 0 0 0 0 Intangible assets 13 12 10 (18.8) 9 8 Other non-current assets 3 3 4 35.3 4 4 Total assets 196 288 290 0.6 327 367 Short-term debt - - - - - Accounts payable 46 95 33 (65.7) 29 31 Other current liabs 17 21 21 0 21 21 Long-term debt/CBs 2 - - - - Provisions/other LT liabs 4 2 2 0 2 2 Shareholder funds 130 174 252 44.9 296 361 Minorities/other equity (3) (3) (17) (20) (48) Total liabs & equity 196 288 290 0.6 327 367 Ratio analysis 2017A 2018A 2019CL (% YoY) 2020CL 2021CL Revenue growth (% YoY) 7.0 24.0 78.8 (20.2) (1.4) Ebitda margin (%) 35.3 35.7 29.6 25.5 24.1 Ebit margin (%) 33.1 34.7 28.9 24.2 22.5 Net profit growth (%) 61.0 30.9 44.7 (33.4) (8.2) Op cashflow growth (% YoY) 183.2 162.7 (100.8) nm (4.3) Capex/sales (%) - - - - - Net debt/equity (%) (63.2) (115.4) (65.6) (66.5) (67.8) Net debt/Ebitda (x) - - - - - ROE (%) 50.6 48.1 49.6 25.7 19.6 ROIC (%) 126.2 556.8 369.1 80.7 66.6 Source: www.clsa.com 2 April 2019 [email protected] 2 Boom or bust? Best World - SELL Boom or bust? Figure 1 Best World’s growth is Best World - Revenue by country over 2005 to 2018 historically anchored to 300 growth in one country. (S$'mil) Indonesia Taiwan China Others Sales in 2006-2007 were primarily driven by 250 Indonesia Similar growth trajectory 200 Strong growth generated during in Taiwan, before an Subsequently, Taiwan drove 2006-07 in Indonesia. Recovery unexpected decline in group’s revenue in 2014- 150 efforts fail to ignite sales growth FY17 2016 before it declined despite GDP recovering unexpectedly 100 Revenue in both countries has failed to recover 50 0 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 Source: CLSA Figure 2 The boom-bust experienced Best World - Indonesia sales have failed to recover post financial crisis despite GDP recovering in Indonesia reveals the 50 (S$'mil) 50% challenges to sustaining Indonesia revenue (LHS) Indonesia % of total revenue (RHS) revenue momentum. Despite 45 45% a strong distributorship and 40 40% GDP recovering, sales have 35 35% failed to recover 30 30% Attempts to strengthen the 25 25% product mix, by adhering to 20 20% the regulatory changes in 15 15% 2009, did not deliver results 10 10% 5 5% 0 0% FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 Source: CLSA Figure 3 We observe a similar pattern Best World - Taiwan sales growth decline in 2017 with Taiwan. Revenue growth between 2014-16 140 (S$'mil) Taiwan revenue (LHS) Taiwan % of total revenue (RHS) 70% was due to successful recruitment of distributors 120 60% Decline in 2017 (sales fell 100 50% 29% YoY) was unexpected and started in 1Q17.